Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4955 SEK | +0.92% | -11.36% | -57.65% |
Apr. 19 | AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract | MT |
Apr. 09 | AegirBio Signs Conditional Agreement for SEK45 Million Loan With Atlas | MT |
Business Summary
Number of employees: 13
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Covid-19 Saliva Test Viraspec
82.2
%
| 13 | 95.9 % | 1 | 82.2 % | -88.99% |
Custom Veritope Development Project
17.8
%
| - | - | 0 | 17.8 % | - |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sweden
82.2
%
| 9 | 69.7 % | 1 | 82.2 % | -84.86% |
United States
17.8
%
| - | - | 0 | 17.8 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marco Witteveen
CEO | Chief Executive Officer | - | 23-06-14 |
Director of Finance/CFO | - | 23-04-18 | |
Vasiliki Fragkou
COO | Chief Operating Officer | - | Oct. 31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 20-01-31 | |
Chairman | 67 | 19-11-30 | |
Sofia Bertling
BRD | Director/Board Member | 54 | 22-05-31 |
Fredrik Häglund
BRD | Director/Board Member | 49 | 20-04-30 |
William Vickery
BRD | Director/Board Member | 57 | 22-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,876,872 | 23,180,538 ( 89.58 %) | 0 | 89.58 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-57.65% | 1.39M | |
+7.71% | 220B | |
+6.25% | 185B | |
+10.60% | 133B | |
+26.73% | 107B | |
-0.57% | 62.91B | |
+15.42% | 53.34B | |
-1.89% | 47.71B | |
-1.91% | 40.29B | |
+11.16% | 39.57B |
- Stock Market
- Equities
- AEGIR Stock
- Company AegirBio AB